New Mountain Capital Terminates Talks with TCP-ASC, R1 RCM Stock Falls
PorAinvest
lunes, 1 de julio de 2024, 11:02 pm ET1 min de lectura
ASC--
R1 RCM (NASDAQ:RCM) shares experienced a significant decline of 9.2% in after-hours trading on March 19, following the announcement that New Mountain Capital had failed to reach an agreement with TCP-ASC on a potential acquisition [1]. Although discussions had been ongoing, no agreement was reached, causing a ripple effect in the financial markets.
New Mountain Capital, a private equity firm owning 32.4% of R1 RCM, and TCP-ASC, an investment vehicle jointly owned by TowerBrook Capital Partners and Ascension Health Alliance, had been considering a potential cash offer of $13.75 per share for all R1's outstanding stock [1]. However, the proposed deal was conditional on a waiver of a standstill agreement, which was not granted.
R1 RCM, in response to the ongoing discussions, formed a special committee of independent directors to evaluate strategic alternatives and directed that any talks between New Mountain Capital and TCP-ASC concerning a potential transaction cease [1]. The company has not approved any of the standstill waivers requested by the shareholders and emphasized that no assurances can be given regarding the outcome or timing of the special committee's review process [1].
This announcement marks a setback for R1 RCM shareholders, who had been anticipating a potential buyout offer. The sudden decline in share price highlights the importance of ongoing negotiations and the potential risks associated with takeover talks.
Sources:
[1] R1 RCM tells shareholders to cease buyout discussions. Becker's Hospital Review. March 11, 2023. https://www.beckershospitalreview.com/finance/r1-rcm-tells-shareholders-to-cease-buyout-discussions.html
NMFC--
RCM--
R1 RCM (NASDAQ:RCM) shares fell 9.2% in after-hours trading after New Mountain Capital announced it failed to reach an agreement with TCP-ASC on a joint proposal for a potential acquisition. Despite ongoing discussions, no agreement was reached. New Mountain had previously sought a waiver to make a takeover offer, proposing a bid of $13.25 per share, down from $13.75. The deal, which also included TowerBrook Capital Partners and Ascension Health as equity co-investors, was conditional on a waiver of a standstill agreement.
R1 RCM (NASDAQ:RCM) shares experienced a significant decline of 9.2% in after-hours trading on March 19, following the announcement that New Mountain Capital had failed to reach an agreement with TCP-ASC on a potential acquisition [1]. Although discussions had been ongoing, no agreement was reached, causing a ripple effect in the financial markets.
New Mountain Capital, a private equity firm owning 32.4% of R1 RCM, and TCP-ASC, an investment vehicle jointly owned by TowerBrook Capital Partners and Ascension Health Alliance, had been considering a potential cash offer of $13.75 per share for all R1's outstanding stock [1]. However, the proposed deal was conditional on a waiver of a standstill agreement, which was not granted.
R1 RCM, in response to the ongoing discussions, formed a special committee of independent directors to evaluate strategic alternatives and directed that any talks between New Mountain Capital and TCP-ASC concerning a potential transaction cease [1]. The company has not approved any of the standstill waivers requested by the shareholders and emphasized that no assurances can be given regarding the outcome or timing of the special committee's review process [1].
This announcement marks a setback for R1 RCM shareholders, who had been anticipating a potential buyout offer. The sudden decline in share price highlights the importance of ongoing negotiations and the potential risks associated with takeover talks.
Sources:
[1] R1 RCM tells shareholders to cease buyout discussions. Becker's Hospital Review. March 11, 2023. https://www.beckershospitalreview.com/finance/r1-rcm-tells-shareholders-to-cease-buyout-discussions.html

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios